PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge
Trial details
- Registry ID
- NCT04754802
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| PH94B Nasal Spray for Anxiety Induced by a Public Speaking ChallengeNCT04754802 | VTGN | Phase 3 | Completed | 2022-06-22Actual |
| PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2NCT05011396 | VTGN | Phase 3 | Terminated | 2022-08-16Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |